Game-changing breakthroughs to redefine the landscape of the renin–angiotensin–aldosterone system in health and disease
- 9 October 2024
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 126, 111459
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- New insights into prostate Cancer from the renin-angiotensin-aldosterone system.Cellular Signalling, 2024
- Principle role of the (pro)renin receptor system in cardiovascular and metabolic diseases: An updateCellular Signalling, 2024
- Unraveling the role of the renin-angiotensin system in severe mental illnesses: An insight into psychopathology and cognitive deficitsCellular Signalling, 2024
- Targeting renal damage: The ACE2/Ang-(1–7)/mas axis in chronic kidney diseaseCellular Signalling, 2024
- Implications of β-Arrestin biased signaling by angiotensin II type 1 receptor for cardiovascular drug discovery and therapeuticsCellular Signalling, 2024
- Glaucoma and the ocular renin-angiotensin-aldosterone system: Update on molecular signalling and treatment perspectivesCellular Signalling, 2024
- Drug Discovery and Development2021
- Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19Cellular Signalling, 2020
- A century old renin–angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathologyCellular Signalling, 2014
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With HypertensionArchives of internal medicine (1960), 2009